“FGF23 at the Intersection of Kidney and Cardiovascular Diseases”
Presented by:
Myles Wolf, MD, MMSc
Director, Center for Translational Metabolism and Health
Institute for Public Health and Medicine
Margaret Gray Morton Professor of Medicine
Feinberg School of Medicine, Northwestern University
Dr. Myles Wolf is the founding Director of the Center for Translational Metabolism and Health within the Institute for Public Health and Medicine at the Feinberg School. The focus of Dr. Wolf's research is disordered mineral metabolism across the spectrum of chronic kidney disease. His primary contributions have been in the area of hormonal regulation of phosphate and vitamin D homeostasis, the physiological role of fibroblast growth factor 23 (FGF23) in health and in chronic kidney disease, and the impact of elevated FGF23 levels on adverse clinical outcomes in patients with kidney disease.
Click here to join through Adobe Connect: http://pmpphmcrc.adobeconnect.com/r354lx4jdmx/
Dec. 6, 2013 (Friday)
11:00am-12:00pm
Northwestern University
Dept. of Preventive Medicine
Stamler Conference Room
680 N. Lake Shore Drive, Suite 1400
Chicago, IL 60611
Levon Guzman
(312) 503-0027
Email